Prevalence Of Hypertension And Its Associated Risk Factors Among The Employees Of Khyber Medical University, A Cross Sectional Study
DOI:
https://doi.org/10.69591/jcihs.3.2.2Keywords:
Hypertension, Prevalence, Risk Factors, University Employees, PakistanAbstract
Background:
Hypertension is a major modifiable risk factor for cardiovascular disease and a leading cause of morbidity and mortality worldwide. Despite its growing burden in developing countries, data on hypertension prevalence among institutional employees in Pakistan remain limited.
Objective:
To determine the prevalence of hypertension and identify associated risk factors among employees of Khyber Medical University (KMU).
Methods:
A descriptive cross-sectional study was conducted among 165 KMU employees aged 21–60 years. Data were collected using a validated structured questionnaire covering sociodemographic characteristics, lifestyle factors, and medical history. Anthropometric measurements were recorded, and blood pressure was measured using a calibrated mercury sphygmomanometer. Data were analyzed using SPSS version 26, and results were expressed as frequencies and percentages.
Results:
Among the participants, 86.1% were males and 13.9% were females. The majority (55.8%) belonged to the 31–45-year age group. Pre-hypertension was the most common blood pressure category (69.7%), followed by stage 1 hypertension (20.0%) and stage 2 hypertension (4.8%). A family history of hypertension was present in 39.4% of participants. Smoking was reported by 25.5% of employees, while varying levels of physical activity were observed. Most participants reported normal dietary salt intake, and only 8.8% were on antihypertensive medication. Pre-hypertension and hypertension were predominantly observed in the 31–45-year age group.
Conclusion:
A high prevalence of pre-hypertension and hypertension was observed among KMU employees, particularly among middle-aged adults. The findings highlight the need for regular blood pressure screening, lifestyle modification, and workplace-based health promotion programs to reduce the future burden of cardiovascular disease.
References
1. World Health Organization. The World Health Report 2001: Mental Health: New Understanding, New Hope. World Health Organization; 2001.
2. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004;18(8):545-551.
3. Rampal L, Rampal S, Azhar MZ, Rahman AR. Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects. Public Health. 2008;122(1):11-18.
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
5. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347-1360.
6. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization; 2009.
7. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983-1992.
8. Ministry of Health Malaysia. Third National Health and Morbidity Survey 2006 (NHMS III): Report. Ministry of Health; 2008.
9. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27(7):1472-1477.
10. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112(23):3562-3568.
11. Sharma S, Kortas C. Hypertension. Medscape. Published online 2010. Accessed January 18, 2010. http://emedicine.medscape.com/article/241381-overview
12. Hypertension. Wikipedia. Accessed January 18, 2010. http://en.wikipedia.org/wiki/Hypertension
13. [This appears to be a continuation of reference 12 rather than a separate reference.]
14. Blood pressure. Wikipedia. Accessed January 18, 2010. http://en.wikipedia.org/wiki/Blood_pressure
15. US Department of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04-5230. National Heart, Lung, and Blood Institute; 2004. Accessed January 15, 2010. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf
16. Department of Health, Executive Yuan. Health and Vital Statistics: I. General Health Statistics. Department of Health; 1996:88.
17. Reynolds E, Baron RB. Hypertension in women and the elderly. Postgrad Med. 1996;100:58-69.
18. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
19. Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet. 1995;345(8953):825-829.
20. Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens. 1988;6(suppl 1):S3-S9.
21. Pathy SJ. Hypertension and associated disease in elderly patients. J Hypertens. 1988;6(suppl 1):S37-S40.
22. Fletcher A, Bulpitt C. Epidemiology of hypertension in the elderly. J Hypertens. 1994;12(suppl 6):S3-S5.
23. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101-106.
24. Potter JF. Hypertension and the elderly. Br Med Bull. 1994;50(2):408-419.
25. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-313. doi:10.1161/01.HYP.25.3.305
26. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
27. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287(8):1003-1010. doi:10.1001/jama.287.8.1003
28. National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04-5230. National Heart, Lung, and Blood Institute; 2004:12.
29. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513-1518.
30. Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and associated factors of prehypertension and hypertension in Iranian population: the Lifestyle Promotion Project (LPP). PLoS One. 2016;11(10):e0165264. doi:10.1371/journal.pone.0165264
31. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013;(133):1-8. Accessed [date needed]. http://www.ncbi.nlm.nih.gov/pubmed/24171916
32. Yu Q, Liu B, Na R, Zhong A. The epidemiology survey of the prevalence and risk factors of hypertension among residents in Zhuanghe, Dalian. J Hypertens. 2016;34(suppl 1):e218. doi:10.1097/01.hjh.0000500477.14631.5a
33. Siddiqui H, Anjum Q, Omair A, Usman J, Rizvi R, Ashfaq T. Risk factors assessment for hypertension in a squatter settlement of Karachi. J Pak Med Assoc. 2005;55(9):390-392.
34. Rapport RS. Hypertension: silent killer. N J Med. 1999;96(3):41-43.
35. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287(8):1003-1010. doi:10.1001/jama.287.8.1003
36. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
37. Gupta R, Guptha S. Strategies for initial management of hypertension. Indian J Med Res. 2010;132(5):531-542. PMID:21150005; PMCID:PMC3028941.
38. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Circulation. 2016;133(9):e? [Reference requires verification before final submission.]
39. Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(1):e004473. doi:10.1161/JAHA.112.004473
40. He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. [Journal details should be verified from the cited BMJ URL before final submission.]
41. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103-109. doi:10.1038/nature10405.
42. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Lancet. 2016;387(10022):957-967.
43. World Health Organization. Guideline for the Pharmacological Treatment of Hypertension in Adults. World Health Organization; 2021. https://www.who.int/publications/i/item/9789240033986
Published
Issue
Section
License
Copyright (c) 2025 Tayyaba Taj, Haleem Ali , Wajeha Taj
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a CC-BY 4.0 License.
